+39 331 386 7522 info@isheo.com

Blog & News

Webinar: Market Access in Italy

Are you looking to launch a new drug in Italy?💊 🇮🇹 When deciding to enter Italy, realise that there not a single health system but many small health systems, each requiring a detailed market entry strategy. Our article shares insight into Market Access in Italy!
Discrete Choice Experiments for Market Access

Discrete Choice Experiments for Market Access

What is Market Access? When learning how to use Discrete Choice Experiments, first we have to look at the bigger picture. Market Access focuses on enabling patients to access treatments beneficial to their health. When a treatment finally survived the long and tedious...

ATMPs & Patient Awareness

ATMPs & Patient Awareness

Webinar ATMPs & Patient AwarenessLearn about patient's awareness for ATMPs and challenges in evidence generation. Our experts discuss the most recent evidence on patient's and public perspectives, barriers to engagement and evaluation of patients' experience....

Evidence Synthesis in the EU

Evidence Synthesis in the EU

In this webinar, ISHEO and AREX Advisor focused on presenting an overview of how different EU countries apply Evidence Synthesis to provide a compass and help professionals navigate the sea of ​​uncertainty created by the vast set of studies present today. Together,...

What are Patient Reported Outcomes

What are Patient Reported Outcomes

During the last webinar, 'Patient-Reported Outcomes' organized by ISHEO into its Access matters webinar series, Davide Integlia, CEO of ISHEO, interviews Linda Abet Webb, CEO of P-COA, focusing on how Patient-Reported Outcomes are becoming increasingly crucial for...

Market Access in Italy

Market Access in Italy

Are you looking to launch a new drug in Italy? When deciding to enter Italy, realise that there not a single health system but many small health systems, each requiring a detailed market entry strategy.